Introduction

Maple syrup urine disease is a metabolic condition caused by a buildup of branched-chain amino acids, such as valine, isoleucine, and leucine, resulting from a deficit in the branched-chain alpha-keto acid dehydrogenase complex. "Maple syrup urine disease" is the term used to describe the smell of these patients' urine. Elevated leucine is the source of the neurological complaints and brain damage. The diagnosis of this autosomal recessive illness is made by plasma amino acid analysis, which can be done with a dried blood spot during newborn screening.¹

Maple syrup urine disease (MSUD) is a rare genetic disorder characterized by a deficiency of the branched-chain alpha-keto acid dehydrogenase enzyme complex, which is essential for metabolizing the branched-chain amino acids (BCAAs): valine, isoleucine, and leucine. All three of the BCAAs accumulate abnormally as a result of this metabolic failure, as do some of their harmful metabolites (particularly, their respective organic acids). Within a few hours of birth, plasma concentrations of BCAAs start to rise in the classic, severe form of MSUD. If left untreated, symptoms usually start to show themselves in the first 24 to 48 hours of life.² If therapy is not received, this illness could get worse. Even with dietary therapy, diseases and stressful situations can lead to higher levels of certain amino acids. Under these circumstances, this could even lead to death. When kids are fed well, they can grow up to be mature adults and keep their health.³

Pathophysiology

Maple syrup urine disease (MSUD) is a metabolic disorder caused by a decrease in the activity of the BCKAD enzyme complex. This occurs due to specific genetic changes in the components of the enzyme, resulting in higher levels of branched-chain amino acids (BCAAs) and toxins that affect the brain and muscles. Breaking down BCAAs is an important part of normal body function. In the mitochondria, branched-chain aminotransferase starts this process by converting leucine, isoleucine, and valine into their respective α-keto acids. Unlike most other forms of amino acid metabolism, this mechanism is mostly performed in skeletal muscle rather than the liver. BCAAs are found in high-protein diets and are essential for protein synthesis, cellular signalling, and glucose metabolism. Among the nine amino acids that are necessary for human survival are these ones.⁴ 

The oxidative decarboxylation of α-ketoacids is initiated by the BCKAD complex during the second phase of BCAA catabolism. As seen in the illustration, this process turns α-ketoacids into acetoacetate, Acetyl-CoA, and succinyl-CoA. The BCKAD complex is composed of several components, such as the subunits E1α and E1β, E2, and E3. Increased amounts of BCAA in the body as a result of pathogenic flaws in these constituents result in MSUD, which causes immune system, skeletal muscle, and central nervous system (CNS) dysfunction, among other symptoms. The effects of dietary BCAA restriction on MSUD have been studied through the creation of many mice models. If therapy is not obtained, excess BCAA buildup in MSUD individuals might cause serious tissue damage.^5,6

Glutamate concentrations within the brain are stabilized by the metabolism of BCAAs. Glutamate is a neurotransmitter in the central nervous system that contributes to learning, memory, and brain development. A variety of neurological illnesses in patients can be brought on by abnormalities in glutamate production, which arise from disorders associated with the metabolizing process of the branched-chain amino acids (BCAAs). The key to avoiding these effects is regulating BCAA levels in plasma concentrations. Moreover, leucine build-up is extremely neurotoxic. Elevated leucine levels can interfere with other essential amino acids in the central nervous system (CNS), such as tyrosine, which plays a key role in protein signalling. This disruption can alter nitrogen balance, further reducing glutamate levels, and lead to brain swelling by disturbing water regulation in the subcortical grey matter. Moreover, studies indicate that α-ketoisocaproic acid, a neurotoxin that is involved in encephalopathic illness, functions as a mediator in leucine metabolism.⁷

Though the specific effects of BCAA abnormalities remain unclear, it is clear that proper metabolism is necessary for human health. While a variety of diseases, such as liver disease, some types of cancer, insulin resistance, and type 2 diabetes mellitus, have been linked to faulty metabolism of BCAAs, it is crucial to remember that MSUD is brought on by genetic anomalies. These associations highlight the diverse roles that abnormal BCAA metabolism plays in human health.

Challenges in managing MSUD in adulthood

Nutrition or Diet: For children with MSUD, the first recommendations are a low-protein diet and a referral to a specialist metabolic dietitian. They might also require medication. The diet's objective is to consume the fewest possible amino acids, with a focus on isoleucine, valine, and leucine. Diets high in protein should be restricted, such as:  Meat, fish, cheese, eggs, and nuts. 

Before feeding your child, your dietitian would advise you to measure and keep an eye on breast milk and baby formula. This contains all the vitamins, minerals, and other amino acids your infant needs. For the rest of their lives, patients with MSUD must follow a low-protein diet to reduce their risk of developing a metabolic crisis. As your child grows older, they will eventually need to learn about diet management and will continue to see a dietitian for guidance and supervision. ^2,3

Observation: Your medical professionals will keep an eye on you if you have MSUD to make sure the three amino acids don't become too much for you to handle. Periodic blood and urine tests will be necessary to track your levels. Depending on the results of the test, your doctor might advise you to modify your diet.⁴ 

Complications: If MSUD is not identified and treated in a timely manner, serious consequences could occur. Acute illness that results in an unanticipated surge in branched-chain amino acid levels can occur in patients adhering to a treatment regimen. The onset of clinical symptoms such excessive exhaustion, irritability and vomiting, and loss of awareness typically signals the onset of this metabolic crisis. The following complications can occur:

• Acute pancreatitis
• Blindness
• Brain edema
• Intracranial ischemia
• Deficiency of essential amino acids, presenting as:
  • Acrodermatitis
  • Growth failure
  • Anemia
  • Hair loss
• Mental illnesses
• Irreversible brain damage
• Metabolic acidosis
• Muscle spasticity
• Osteoporosis
• Recurrent esophageal candidiasis (related to T-cell suppression)
• Convulsions

Management strategies

Recommended Intensive Care Unit Surveillance: Laboratory monitoring for patients with acute exacerbations receiving care in the critical care unit should comprise:

• Serum glucose: Measured every 4 to 6 hours
• Electrolytes and serum osmolality: Measured every 6 to 12 hours
• Serum phosphorus, magnesium, and plasma amino acids: Measured every 12 to 24 hours
• Serum amylase, transaminases, and lipase: Measured every 24 to 48 hours⁸

Transplanting an orthotopic liver: About 10% of BCKAD activity occurs in the liver, making it a key player in metabolizing branched-chain amino acids. Remarkably, restoring just 9% to 13% of normal BCKDH enzyme activity can effectively regulate this process. For patients with classic (severe) MSUD who cannot manage the condition through diet alone, liver transplantation is a highly recommended option. Typically, a liver from an unrelated deceased donor is used for the procedure. Post-transplantation, the residual BCKAD activity often increases to levels consistent with mild MSUD. While the transplant cannot reverse prior brain damage, cognitive dysfunction, or mental health issues, it significantly reduces the risk of metabolic crises and minimizes the need for strict dietary restrictions.⁹

The most compelling advantage of liver transplantation is its ability to halt the development of new symptoms. Studies on transplant outcomes suggest that when performed shortly after diagnosis, the procedure can lead to little or no long-term neurological impairment, offering patients a chance at a more stable and healthier life. Indications for liver transplantation include:

• Recurring metabolic adjustments 
• Low standard of living 
• Traditional (severe) MSUD
• Psychomotor impairments
• Inadequate regulation of metabolism¹⁰

Objectives of laboratory surveillance

• Age-appropriate consumption of leucine at a concentration of 150–300 µmol/L is recommended
• The concentration of plasma isoleucine is nearly identical to the concentration of plasma leucine
• Indicators of the sufficiency of omega-3 essential fatty acids, calcium, zinc magnesium, folate, and selenium⁸

Management during pregnancy

Thanks to advancements in infant screening and preventive care, more individuals with MSUD are now surviving to childbearing age. Women with classic MSUD can successfully give birth to healthy babies. For example, two women with biallelic pathogenic BCKDHA mutations who underwent liver transplants were able to conceive. During their pregnancies, they continued taking the immunosuppressant sirolimus and did not follow any specific dietary restrictions. Despite this, both delivered healthy babies, highlighting the potential for positive outcomes in MSUD-affected pregnancies after liver transplantation.^2,3

Elevated maternal plasma concentrations of phenylalanine and leucine are likely teratogenic, posing risks to the developing fetus. For women with MSUD planning a pregnancy, strict metabolic management is essential both before and during gestation. By carefully maintaining the mother's plasma levels of branched-chain amino acids (BCAAs) within the range of 100 to 300 μmol/L, it is possible to deliver a healthy baby.¹¹

Maternal BCAA and protein requirements rise as the placenta and foetus develop, and regular monitoring of plasma amino acid concentrations and foetal growth may be required to prevent crucial amino acid shortages.¹²

Mothers with MSUD face risks during the postpartum phase due to potential metabolic decompensation. Factors such as internal blood sequestration, uterine involution, and the catabolic stress of childbirth can trigger complications. To minimize risks, it is highly recommended that delivery take place in a metabolic referral centre with appropriate monitoring and care.¹³

Summary

Maple Syrup Urine Disease (MSUD) is a rare inherited condition caused by a defect in the BCKAD enzyme complex, leading to an inability to break down branched-chain amino acids (BCAAs) like leucine, isoleucine, and valine. If untreated, toxic levels of these amino acids can cause severe neurological damage, brain swelling, and even death. Management involves a strict low-protein diet and careful monitoring of amino acid levels. For severe cases, liver transplantation offers a long-term solution, reducing the risk of metabolic crises. Pregnancy in women with MSUD requires meticulous metabolic control, while the postpartum period demands close monitoring to prevent complications.